ONCOLYTICS BIOTECH INC
ONCY
ONCY was delisted on the 4th of November, 2015.
30 hedge funds and large institutions have $2.38M invested in ONCOLYTICS BIOTECH INC in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 10 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
12% less funds holding
Funds holding: 34 → 30 (-4)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
69% less capital invested
Capital invested by funds: $7.72M → $2.38M (-$5.34M)
76% less call options, than puts
Call options by funds: $5K | Put options by funds: $21K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$59.6K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
+$42.1K |
| 3 |
Jane Street
New York
|
+$30.5K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$25.4K |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$24.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$1.75M |
| 2 |
AII
AGF Investments Inc
Toronto,
Ontario, Canada
|
-$253K |
| 3 |
First Eagle Investment Management
New York
|
-$243K |
| 4 |
VFS
VSR Financial Services
Overland Park,
Kansas
|
-$68.8K |
| 5 |
Canada Life
Winnipeg,
Manitoba, Canada
|
-$67K |
ONCY Hedge Fund Activity: Q3 2014 in Review
30 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in ONCOLYTICS BIOTECH INC (ONCY) for Q3 2014, worth a combined $2.38M — down 69% from $7.72M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ONCY and 6 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 9 added.
The largest buyer was Goldman Sachs, adding an estimated $59.6K. The largest seller was 1832 Asset Management, cutting an estimated $1.75M.
- 30 institutional investors held ONCOLYTICS BIOTECH INC (ONCY) as of Q3 2014, down from 34 in Q2 2014.
- Funds reported $2.38M of ONCOLYTICS BIOTECH INC stock for Q3 2014, down 69% quarter-over-quarter.
- 6 funds opened new ONCOLYTICS BIOTECH INC positions in Q3 2014 and 10 closed out, a net change of -4 holders.
- The largest ONCOLYTICS BIOTECH INC buyer in Q3 2014 was Goldman Sachs, an estimated $59.6K added.
- The largest ONCOLYTICS BIOTECH INC seller in Q3 2014 was 1832 Asset Management, an estimated $1.75M sold.
Based on aggregated 13F filings for Q3 2014.